NSPR logo

InspireMD (NSPR) Cash From Financing

Annual CFF

$37.53 M
+$37.67 M+26910.00%

December 31, 2023


Summary


Performance

NSPR Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNSPRcash flowmetrics:

Quarterly CFF

-$965.00 K
-$18.82 M-105.40%

September 30, 2024


Summary


Performance

NSPR Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNSPRcash flowmetrics:

TTM CFF

$16.89 M
-$965.00 K-5.40%

September 30, 2024


Summary


Performance

NSPR TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNSPRcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

NSPR Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+10000.0%-100.0%-55.0%
3 y3 years+128.9%-2657.1%-56.8%
5 y5 years+180.7%-107.9%+2.2%

NSPR Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high>+9999.0%-102.6%at low-55.0%>+9999.0%
5 y5-yearat high>+9999.0%-102.6%at low-67.2%>+9999.0%
alltimeall timeat high>+9999.0%-102.6%+8.4%-67.2%+795.9%

InspireMD Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$965.00 K(-105.4%)
$16.89 M(-5.4%)
Jun 2024
-
$17.85 M(>+9900.0%)
$17.85 M(-52.4%)
Mar 2024
-
$0.00(0.0%)
$37.53 M(0.0%)
Dec 2023
$37.53 M(<-9900.0%)
$0.00(0.0%)
$37.53 M(0.0%)
Sep 2023
-
$0.00(-100.0%)
$37.53 M(+0.3%)
Jun 2023
-
$37.53 M(>+9900.0%)
$37.43 M(<-9900.0%)
Mar 2023
-
$0.00(0.0%)
-$140.00 K(0.0%)
Dec 2022
-$140.00 K(-100.4%)
$0.00(-100.0%)
-$140.00 K(0.0%)
Sep 2022
-
-$103.00 K(+178.4%)
-$140.00 K(+94.4%)
Jun 2022
-
-$37.00 K(<-9900.0%)
-$72.00 K(+111.8%)
Mar 2022
-
$0.00(0.0%)
-$34.00 K(-100.1%)
Dec 2021
$35.03 M(+113.7%)
$0.00(-100.0%)
$35.03 M(-10.4%)
Sep 2021
-
-$35.00 K(-3600.0%)
$39.10 M(-0.3%)
Jun 2021
-
$1000.00(-100.0%)
$39.23 M(-23.8%)
Mar 2021
-
$35.07 M(+762.0%)
$51.46 M(+213.9%)
Dec 2020
$16.39 M(+158.8%)
$4.07 M(+4420.0%)
$16.39 M(+33.0%)
Sep 2020
-
$90.00 K(-99.3%)
$12.33 M(-25.4%)
Jun 2020
-
$12.23 M(>+9900.0%)
$16.53 M(+161.4%)
Mar 2020
-
$3000.00(-25.0%)
$6.32 M(-0.2%)
Dec 2019
$6.33 M(-52.6%)
$4000.00(-99.9%)
$6.33 M(-0.2%)
Sep 2019
-
$4.29 M(+111.1%)
$6.35 M(-26.5%)
Jun 2019
-
$2.03 M(>+9900.0%)
$8.64 M(-19.0%)
Mar 2019
-
$16.00 K(-15.8%)
$10.67 M(-20.2%)
Dec 2018
$13.37 M(+188.6%)
$19.00 K(-99.7%)
$13.37 M(-5.2%)
Sep 2018
-
$6.57 M(+61.8%)
$14.10 M(+87.5%)
Jun 2018
-
$4.06 M(+49.4%)
$7.52 M(+123.3%)
Mar 2018
-
$2.72 M(+262.4%)
$3.37 M(-27.3%)
Dec 2017
$4.63 M
$750.00 K(-7600.0%)
$4.63 M(+63.7%)
DateAnnualQuarterlyTTM
Sep 2017
-
-$10.00 K(-88.9%)
$2.83 M(-81.6%)
Jun 2017
-
-$90.00 K(-102.3%)
$15.42 M(+1.6%)
Mar 2017
-
$3.98 M(-478.3%)
$15.17 M(+29.6%)
Dec 2016
$11.70 M(+35.8%)
-$1.05 M(-108.4%)
$11.70 M(-0.6%)
Sep 2016
-
$12.58 M(-3842.9%)
$11.77 M(-773.2%)
Jun 2016
-
-$336.00 K(-165.1%)
-$1.75 M(-28.0%)
Mar 2016
-
$516.00 K(-152.2%)
-$2.43 M(-128.2%)
Dec 2015
$8.62 M(+4.2%)
-$988.00 K(+5.1%)
$8.62 M(-46.3%)
Sep 2015
-
-$940.00 K(-7.4%)
$16.05 M(-15.2%)
Jun 2015
-
-$1.01 M(-108.8%)
$18.93 M(-4.9%)
Mar 2015
-
$11.56 M(+79.3%)
$19.91 M(+140.7%)
Dec 2014
$8.27 M(-15.3%)
$6.45 M(+232.5%)
$8.27 M(+353.5%)
Sep 2014
-
$1.94 M(-5202.6%)
$1.82 M(-1686.1%)
Jun 2014
-
-$38.00 K(-50.6%)
-$115.00 K(-100.8%)
Mar 2014
-
-$77.00 K(-100.5%)
$14.02 M(-7.3%)
Dec 2013
$9.76 M(-35.4%)
-
-
Jun 2013
-
$14.09 M(<-9900.0%)
$15.12 M(+1369.7%)
Jun 2013
$15.12 M(+55.1%)
-
-
Mar 2013
-
-$20.00 K(-103.2%)
$1.03 M(+7.7%)
Dec 2012
-
$617.00 K(+42.8%)
$955.00 K(+291.4%)
Sep 2012
-
$432.00 K(-559.6%)
$244.00 K(-78.2%)
Jun 2012
$9.75 M(-8.6%)
-
-
Mar 2012
-
-$94.00 K(0.0%)
$1.12 M(-89.5%)
Dec 2011
$10.67 M(>+9900.0%)
-$94.00 K(-106.7%)
$10.67 M(-0.9%)
Sep 2011
-
$1.41 M(-1535.7%)
$10.76 M(+15.0%)
Jun 2011
-
-$98.00 K(-101.0%)
$9.36 M(-1.0%)
Mar 2011
-
$9.45 M
$9.45 M
Jun 2010
$20.00 K(>+9900.0%)
-
-
Jun 2009
$0.00
-
-

FAQ

  • What is InspireMD annual cash flow from financing activities?
  • What is the all time high annual CFF for InspireMD?
  • What is InspireMD annual CFF year-on-year change?
  • What is InspireMD quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for InspireMD?
  • What is InspireMD quarterly CFF year-on-year change?
  • What is InspireMD TTM cash flow from financing activities?
  • What is the all time high TTM CFF for InspireMD?
  • What is InspireMD TTM CFF year-on-year change?

What is InspireMD annual cash flow from financing activities?

The current annual CFF of NSPR is $37.53 M

What is the all time high annual CFF for InspireMD?

InspireMD all-time high annual cash flow from financing activities is $37.53 M

What is InspireMD annual CFF year-on-year change?

Over the past year, NSPR annual cash flow from financing activities has changed by +$37.67 M (+26910.00%)

What is InspireMD quarterly cash flow from financing activities?

The current quarterly CFF of NSPR is -$965.00 K

What is the all time high quarterly CFF for InspireMD?

InspireMD all-time high quarterly cash flow from financing activities is $37.53 M

What is InspireMD quarterly CFF year-on-year change?

Over the past year, NSPR quarterly cash flow from financing activities has changed by -$965.00 K (-100.00%)

What is InspireMD TTM cash flow from financing activities?

The current TTM CFF of NSPR is $16.89 M

What is the all time high TTM CFF for InspireMD?

InspireMD all-time high TTM cash flow from financing activities is $51.46 M

What is InspireMD TTM CFF year-on-year change?

Over the past year, NSPR TTM cash flow from financing activities has changed by -$20.64 M (-55.00%)